<DOC>
	<DOCNO>NCT01226095</DOCNO>
	<brief_summary>This prospective , multi-center , post-marketing observational study evaluate effectiveness compliance ibuprofen sustain release form treatment Egyptian osteoarthritic patient .</brief_summary>
	<brief_title>Evaluation Effectiveness , Compliance Ibuprofen Sustained Release Form Treatment Egyptian Osteoarthritic Patients</brief_title>
	<detailed_description>This prospective , longitudinal , multicenter observational study conduct clinical practice set study product use osteoarthritis patient indicate approved package insert ; dose regimen Brufen retard 2 tablet single dose daily .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Patients seek treatment osteoarthritis clinical radiological evidence disease , Male female , age â‰¥ 18 Designated treatment Ibuprofen sustain release form ( Brufen Retard ) accord best criterion physician decide treat patient accord labeled indication dose 4 week . Patients give write informed consent participate study Patients currently take non steroidal anti inflammatory drug ( NSAIDs ) , complete initial washout phase 10 day depend half life drug take Contraindications describe company core data sheet ( CCDS ) specifically Patients active peptic ulcer Patients present reaction hypersensitivity ( asthma , rhinitis urticaria ) ibuprofen antiinflammatory non steroid Patients active cardiovascular disease take aspirin/warfarin prophylaxis myocardial infarction ( MI ) stroke Patients moderate severe renal disease Patients moderate severe hepatic disease Patients Crohn 's disease Patients include currently another study Women childbearing potential must pregnant Any patient investigator consider ineligible study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Pain</keyword>
	<keyword>Morning stiffness</keyword>
</DOC>